- Home
- MIN vs OSUR Comparison
MIN vs OSUR Comparison
Compare MIN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIN | OSUR |
|---|---|---|
| Founded | 1988 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.5M | 215.9M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | MIN | OSUR |
|---|---|---|
| Price | $2.47 | $2.94 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 284.1K | ★ 471.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 7.31% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $30.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.44 | $2.08 |
| 52 Week High | $2.72 | $3.76 |
Technical Indicators
Market Signals| Indicator | MIN | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 47.94 | 44.01 |
| Support Level | $2.45 | $2.87 |
| Resistance Level | $2.52 | $2.96 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 33.33 | 15.11 |
Price Performance
Historical ComparisonAbout MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.